{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+SC+Injection&page=32", "query": { "intervention": "Placebo SC Injection", "page": 32 }, "page_size": 10 }, "pagination": { "page": 32, "page_size": 10, "total_count": 835, "total_pages": 84, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+SC+Injection&page=33&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+SC+Injection&page=31&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T20:54:27.511Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03705169", "title": "Pharmacokinetics and Safety of SAR441236", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV-1-infection" ], "interventions": [ { "name": "SAR441236", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 52, "start_date": "2019-05-20", "completion_date": "2022-04-04", "has_results": true, "last_update_posted_date": "2024-01-12", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03705169" }, { "nct_id": "NCT02134925", "title": "Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Adenoma", "Colorectal Carcinoma", "Colorectal Conventional Adenoma With Severe Dysplasia", "Colorectal Tubulovillous Adenoma" ], "interventions": [ { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "MUC1 Peptide-Poly-ICLC Vaccine", "type": "BIOLOGICAL" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Saline", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 110, "start_date": "2014-06-23", "completion_date": "2027-03-09", "has_results": true, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 6, "location_summary": "Boston, Massachusetts • Rochester, Minnesota • Kansas City, Missouri + 2 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02134925" }, { "nct_id": "NCT03001297", "title": "Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "MEDI5884 Dose 1", "type": "BIOLOGICAL" }, { "name": "MEDI5884 Dose 2", "type": "BIOLOGICAL" }, { "name": "MEDI5884 Dose 3", "type": "BIOLOGICAL" }, { "name": "MEDI5884 Dose 4", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 64, "start_date": "2017-01-17", "completion_date": "2018-08-10", "has_results": false, "last_update_posted_date": "2018-08-22", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03001297" }, { "nct_id": "NCT05565742", "title": "A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lipoprotein Disorder" ], "interventions": [ { "name": "LY3819469", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 320, "start_date": "2022-10-20", "completion_date": "2024-10-17", "has_results": true, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 19, "location_summary": "Mesa, Arizona • Pasadena, California • Santa Clarita, California + 16 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Pasadena", "state": "California" }, { "city": "Santa Clarita", "state": "California" }, { "city": "Spring Hill", "state": "Florida" }, { "city": "Sun City", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05565742" }, { "nct_id": "NCT01242488", "title": "Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "CDP6038", "type": "BIOLOGICAL" }, { "name": "Tocilizumab (Actemra or RoActemra)", "type": "BIOLOGICAL" }, { "name": "Placebo sc", "type": "OTHER" }, { "name": "Placebo iv", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 221, "start_date": "2010-11", "completion_date": "2012-06", "has_results": false, "last_update_posted_date": "2024-07-17", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 74, "location_summary": "Mesa, Arizona • Paradise Valley, Arizona • Scottsdale, Arizona + 66 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01242488" }, { "nct_id": "NCT07801456", "title": "A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cytomegalovirus (CMV)", "HIV (Human Immunodeficiency Virus)" ], "interventions": [ { "name": "VIR-1388", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2026-10-15", "completion_date": "2028-02-02", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 2, "location_summary": "Birmingham, Alabama • Boston, Massachusetts", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07801456" }, { "nct_id": "NCT03809663", "title": "A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Tezepelumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 251, "start_date": "2019-03-15", "completion_date": "2020-12-22", "has_results": true, "last_update_posted_date": "2022-03-10", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 16, "location_summary": "Fountain Valley, California • Santa Monica, California • Alpharetta, Georgia + 12 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Alpharetta", "state": "Georgia" }, { "city": "Springfield", "state": "Illinois" }, { "city": "West Dundee", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03809663" }, { "nct_id": "NCT06290128", "title": "A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Polyneuropathy, Inflammatory Demyelinating, Chronic" ], "interventions": [ { "name": "Riliprubart", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 109, "start_date": "2024-07-12", "completion_date": "2027-10-31", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 28, "location_summary": "Homewood, Alabama • Los Angeles, California • Orange, California + 24 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT06290128" }, { "nct_id": "NCT03912337", "title": "Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Erenumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 29, "start_date": "2019-12-04", "completion_date": "2021-07-28", "has_results": true, "last_update_posted_date": "2022-07-20", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Los Angeles, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Basalt", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03912337" }, { "nct_id": "NCT05492500", "title": "A Study of Ponsegromab in People With Heart Failure", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Main cohort (Cohort A): Ponsegromab low dose", "type": "DRUG" }, { "name": "Main cohort (Cohort A): Ponsegromab medium dose", "type": "DRUG" }, { "name": "Main cohort (Cohort A): ponsegromab high dose", "type": "DRUG" }, { "name": "Main cohort (Cohort A): Matched placebo", "type": "OTHER" }, { "name": "Open-label, PK Cohort (Cohort B): ponsegromab low dose", "type": "DRUG" }, { "name": "Open-label, PK Cohort (Cohort B): ponsegromab medium dose", "type": "DRUG" }, { "name": "Open-label, PK Cohort (Cohort B): ponsegromab high dose", "type": "DRUG" }, { "name": "Optional Cohort C: Ponsegromab low dose", "type": "DRUG" }, { "name": "Optional Cohort C: Matched placebo", "type": "OTHER" }, { "name": "Optional Cohort D: Ponsegromab high dose", "type": "DRUG" }, { "name": "Optional Cohort D: Matched placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 455, "start_date": "2022-09-26", "completion_date": "2025-03-05", "has_results": true, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-11-04T20:54:27.511Z", "location_count": 22, "location_summary": "Fairhope, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 13 more", "locations": [ { "city": "Fairhope", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Hazel Crest", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05492500" } ] }